Growth Metrics

Usana Health Sciences (USNA) Non-Current Assets (2016 - 2026)

Usana Health Sciences has reported Non-Current Assets over the past 16 years, most recently at $444.7 million for Q2 2026.

  • Quarterly Non-Current Assets fell 4.4% to $444.7 million in Q2 2026 from the year-ago period, while the trailing twelve-month figure was $1.8 billion through Apr 2026, up 34.23% year-over-year, with the annual reading at $454.5 million for FY2026, 3.09% down from the prior year.
  • Non-Current Assets was $444.7 million for Q2 2026 at Usana Health Sciences, down from $454.5 million in the prior quarter.
  • Over five years, Non-Current Assets peaked at $472.7 million in Q2 2025 and troughed at $85.2 million in Q2 2022.
  • The 5-year median for Non-Current Assets is $215.0 million (2022), against an average of $274.7 million.
  • The largest YoY upside for Non-Current Assets was 155.98% in 2022 against a maximum downside of 59.54% in 2022.
  • A 5-year view of Non-Current Assets shows it stood at $212.2 million in 2022, then increased by 1.34% to $215.0 million in 2023, then skyrocketed by 118.13% to $469.0 million in 2024, then fell by 1.38% to $462.5 million in 2025, then decreased by 3.85% to $444.7 million in 2026.
  • Per Business Quant, the three most recent readings for USNA's Non-Current Assets are $444.7 million (Q2 2026), $454.5 million (Q1 2026), and $462.5 million (Q3 2025).